C-reactive protein and genetic variants and cognitive decline in old age: The prosper study

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Mooijaart, Simon P ^a   Sattar, Naveed ^b   Trompet, Stella ^a   Polisecki, Eliana ^c   de Craen, Anton J M ^a   Schaefer, Ernst J ^c   Jahn, Sabine E ^c   van Himbergen, Thomas ^c   Welsh, Paul ^d   Ford, Ian ^d   Stott, David J ^d   Westendorp, Rudi G J ^a,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c TUFTS UNIVERSITY   (United States)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e Netherlands Consortium for Healthy Ageing   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN;

AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LETTER DIGIT TEST; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PICTURE LEARNING TEST; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; STROOP TEST; TASK PERFORMANCE; BLOOD; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METABOLISM; PHYSIOLOGY;

AGED; AGED, 80 AND OVER; AGING; C-REACTIVE PROTEIN; COGNITION DISORDERS; FEMALE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC;

EID: 80052534019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023890     Document Type: Article

References (25)

1. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, et al. (2002) Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59: 371-378.
2. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, et al. (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61: 668-672.
3. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, et al. (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52: 168-174.
4. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frolich M, et al. (2007) Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 55: 708-716.
5. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, et al. (2003) Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61: 76-80.
6. Teunissen CE, van Boxtel MP, Bosma H, Bosmans E, Delanghe J, De BC, et al. (2003) Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 134: 142-150.
7. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, et al. (2005) Serum inflammatory proteins and cognitive decline in older persons. Neurology 64: 1371-1377.
8. van den Biggelaar AH, Gussekloo J, de Craen AJ, Frolich M, Stek ML, et al. (2007) Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 42: 693-701.
9. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, et al. (2005) Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 4: 371-380.
10. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, et al. (2008) Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359: 1897-1908.
11. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360: 1623-1630.
12. Trompet S, van VP, de Craen AJ, Jolles J, Buckley BM, et al. (2010) Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol 257: 85-90.
13. Havekes LM, de KP, Beisiegel U, Havinga J, Smit M, et al. (1987) A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res 28: 455-463.
14. Houx PJ, Shepherd J, Blauw GJ, Murphy MB, Ford I, et al. (2002) Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry 73: 385-389.
15. Brand N, Jolles J, (1985) Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol 112: 201-210.
16. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
17. Harel O, Zhou XH, (2007) Multiple imputation: review of theory, implementation and software. Stat Med 26: 3057-3077.
18. Wallenstein S, Hodge SE, Weston A, (1998) Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 15: 173-181.
19. Gueorguieva R, Krystal JH, (2004) Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 61: 310-317.
20. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG, (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27: 1133-1163.
21. Marioni RE, Deary IJ, Murray GD, Lowe GD, Rafnsson SB, et al. (2010) Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samples. Behav Genet 40: 3-11.
22. Lusis AJ, (2000) Atherosclerosis. Nature 407: 233-241.
23. Ott A, Stolk RP, van HF, Pols HA, Hofman A, et al. (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53: 1937-1942.
24. Welsh P, Woodward M, Rumley A, Lowe G, (2008) Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 141: 852-861.
25. Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, et al. (2007) Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc 55: 1777-1785.